PMC:7377212 / 657-901 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T14","span":{"begin":44,"end":52},"obj":"SP_7"},{"id":"T15","span":{"begin":62,"end":75},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T16","span":{"begin":110,"end":116},"obj":"NCBITaxon:4751"},{"id":"T17","span":{"begin":145,"end":153},"obj":"SP_7"},{"id":"T18","span":{"begin":165,"end":174},"obj":"UBERON:0002048"},{"id":"T19","span":{"begin":233,"end":241},"obj":"SP_7"},{"id":"T59221","span":{"begin":44,"end":52},"obj":"SP_7"},{"id":"T9877","span":{"begin":62,"end":75},"obj":"CHEBI:35718;CHEBI:35718"},{"id":"T12804","span":{"begin":110,"end":116},"obj":"NCBITaxon:4751"},{"id":"T73228","span":{"begin":145,"end":153},"obj":"SP_7"},{"id":"T60783","span":{"begin":165,"end":174},"obj":"UBERON:0002048"},{"id":"T68907","span":{"begin":233,"end":241},"obj":"SP_7"}],"text":"cent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 as"}

{"project":"LitCovid-PubTator","denotations":[{"id":"37","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"cent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 as"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":44,"end":52},"obj":"Disease"},{"id":"T16","span":{"begin":120,"end":129},"obj":"Disease"},{"id":"T17","span":{"begin":145,"end":153},"obj":"Disease"},{"id":"T18","span":{"begin":175,"end":188},"obj":"Disease"},{"id":"T19","span":{"begin":190,"end":194},"obj":"Disease"},{"id":"T20","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"cent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 as"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":62,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"cent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 as"}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":89,"end":222},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"cent review found that 72% of patients with COVID-19 received antimicrobial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.\n\nCases of COVID-19 as"}